Please Wait

Applying Filters...

FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Mupirocin Calcium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

16 API Suppliers, 9 USDMF, 4 CEP/COS, 2 JDMF, 5 EU WC, 5 NDC API, 10 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

21 FDF Dossiers, 8 FDA Orange Book, 9 Europe, 1 Canada, 2 South Africa, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;NASAL - EQ 2% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - EQ 2% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 Pharm-RX Chemical, 2 Nanjing Well Pharmaceutical, 3 Actylis, 4 BASF, 2 CD Formulation, 1 Finar

EXCIPIENTS BY APPLICATIONS

8 Topical, 5 Solubilizers, 3 Thickeners and Stabilizers, 2 Controlled & Modified Release, 1 Granulation, 1 Direct Compression, 1 Lubricants & Glidants, 1 Rheology Modifiers, 1 Coating Systems & Additives, 1 API Stability Enhancers, 1 Parenteral

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 5 News #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 1 Regulatory FDF Prices

MARKET PLACE

7 APIs, 1 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM, 1 Others

$ Xls

Filters

OINTMENT;NASAL - EQ 2% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - EQ 2% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

X

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Mupirocin Calcium

Mupirocin Calcium

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

16 API Suppliers

9 USDMF

4 CEP/COS

2 JDMF

5 EU WC

5 NDC API

10 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

21 FDF Dossiers

8 FDA Orange Book

9 Europe

1 Canada

2 South Africa

1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;NASAL - EQ 2% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - EQ 2% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

1 Pharm-RX Chemical

2 Nanjing Well Pharmaceutical

3 Actylis

4 BASF

2 CD Formulation

1 Finar

EXCIPIENTS BY APPLICATIONS

8 Topical

5 Solubilizers

3 Thickeners and Stabilizers

2 Controlled & Modified Release

1 Granulation

1 Direct Compression

1 Lubricants & Glidants

1 Rheology Modifiers

1 Coating Systems & Additives

1 API Stability Enhancers

1 Parenteral

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

5 News #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions

1 Regulatory FDF Prices

MARKET PLACE

7 APIs

1 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM

1 Others

Filters

OINTMENT;NASAL - EQ 2% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM;TOPICAL - EQ 2% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons